Keyphrases
Genomic Characterization
100%
Vulvar Squamous Cell Carcinoma
100%
High-risk Human Papillomavirus (HR-HPV)
60%
Tumor Protein p53 (TP53)
40%
Cancer mutations
40%
Missense mutation
20%
Whole Exome Sequencing
20%
Rare Diseases
20%
Therapeutic Potential
20%
Relevant Genes
20%
Signaling Pathway
20%
Recurring
20%
Mutually Exclusive
20%
Therapeutic Strategies
20%
Recurrent Disease
20%
Advanced Disease
20%
Increased Incidence
20%
FIGO Stage
20%
TP53 mutation
20%
Tuberous Sclerosis Complex
20%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
20%
PIK3CA
20%
HPV16
20%
KMT2D
20%
DOCK2
20%
MSH6
20%
Etiological Pathways
20%
Variant Discovery
20%
SYNE1
20%
Illumina HiSeq4000
20%
Lichen Sclerosus
20%
Short Variants
20%
NBPF1
20%
NSD1
20%
ANNOVAR
20%
SYNE2
20%
MACF1
20%
Human Papillomavirus Negative
20%
Medicine and Dentistry
Wart Virus
100%
Squamous Cell Carcinoma
100%
Malignant Neoplasm
75%
Rare Disease
25%
Recurrent Disease
25%
Missense Mutation
25%
Human Papillomavirus Type 16
25%
Exome Sequencing
25%
Cell Signaling Pathway
25%
Lichen Sclerosus
25%
Microtubule Associated Protein 2
25%
Vulva Carcinoma
25%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Wart Virus
100%
NSD1
25%
TSC2
25%
MACF1
25%
SYNE2
25%
Exome Sequencing
25%
Missense Mutation
25%
Human Papillomavirus Type 16
25%
MSH6
25%
Immunology and Microbiology
Squamous Cell
100%
Wart Virus
100%
Whole Exome Sequencing
25%
Missense Mutation
25%
Human Papillomavirus Type 16
25%
MSH6
25%